Nursing and External Applications for Constipation

Nursing measures

Ground psyllium husks: 2 tsp. in 250 ml liquid
(not for opiate-induced constipation) 

Milk and honey enema: 3 tsp. honey in 500 ml warm milk
For instructions, see: https://www.pflege-vademecum.de/m-h-einlauf.php?locale=en 

External applications

Abdominal compresses with chamomile tea
have a warming and antispasmodic effect

Liver compresses with yarrow tea at midday
warm through and stimulate the digestive process
See: http://www.pflege-vademecum.de/schafgarben_leberwickel.php?locale=en

Abdominal compresses with Oxalis, Folium 20% tincture (Weleda)
For instructions, see: http://www.pflege-vademecum.de/oxalis_essenz_bauchwickel.php?locale=en  

Abdominal compresses with Oxalis e planta tota W 10%, Oleum
relaxing, decongestive, stimulates elimination

Abdominal compresses with anise caraway fennel tea
relieving, soothing for spastic constipation

Rhythmical embrocation of the thighs with Oxalis, Folium 10% ointment WELEDA or Lavender 10% oil WALA, WELEDA
stimulates elimination

Rhythmical embrocation of the abdomen with Melissa oil WALA
has a calming and relaxing effect 

Gesellschaft Anthroposophischer Ärzte in Deutschland/GAÄD, Medizinische Sektion am Goetheanum (Hg.) Vademecum Anthroposophische Arzneimittel. 4. Aufl. München 2017. www.vademecum.org

Debus M. Medikamentöse Begleitbehandlung bei onkologischen Erkrankungen. Der Merkurstab 2009;62(4):320-325.



Research news

Real World Data Study: Factors Associated with Self-Reported Post/Long-COVID    
Little evidence exists on the risk factors that contribute to Post/Long-COVID (PLC). In a recent prospective study, 99 registered people reported suffering from PLC symptoms - most commonly from fatigue, dyspnea, decreased strenght, hyposmia, and memory loss. The study results show, for example, that people, who suffered from COVID-19-associated anxiety, hyposmia, or palpitations were up to eight times more at risk of developing PLC than people without these symptoms. Individuals who suffered from fatigue during COVID-19 treatment were seven times more at risk to develop PLC fatigue than those who did not show this symptom. Overall, the results revealed that 13% of the study participants who had previously suffered from COVID-19 subsequently reported having PLC. The article is published open access: 
https://doi.org/10.3390/ijerph192316124.


Further information on Anthroposophic Medicine